Crossmark

Lenvatinib in the treatment of unresectable hepatocellular carcinoma: a systematic review of economic evaluations

Published Online: 2023-05-19

Published Print: 2023-07

Authors

Mohammadnezhad, Ghader

Noqani, Hesam

Rostamian, Parand

Sattarpour, Melika

Arabloo, Jalal
License Information

Text and Data Mining valid from 2023-05-19

Version of Record valid from 2023-05-19
More Information

Article History

Received: 13 February 2023

Accepted: 27 April 2023

First Online: 19 May 2023

Declarations

:

: The authors declare no competing interests.

Document is current